tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

XENE Stock Latest News

Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days
Press ReleasesXenon Pharmaceuticals to Present at the Stifel 2023 CNS Days
2d ago
XENE
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Press ReleasesXenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
23d ago
XENE
Wells Fargo downgrades Cerevel on lack of catalysts until 2024
The FlyWells Fargo downgrades Cerevel on lack of catalysts until 2024
30d ago
CERE
TVTX
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
Press ReleasesXenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
30d ago
XENE
Xenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
Press ReleasesXenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
1M ago
XENE
3 Stocks to Buy Today, 02/01/2023, According to Top Analysts
Stock Analysis & Ideas3 Stocks to Buy Today, 02/01/2023, According to Top Analysts
2M ago
CZR
XENE
Xenon Pharmaceuticals outlines key milestone opportunities for 2023
The FlyXenon Pharmaceuticals outlines key milestone opportunities for 2023
2M ago
NBIX
XENE
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
Press ReleasesXenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
2M ago
XENE
Xenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
Press ReleasesXenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
3M ago
XENE
Xenon Pharmaceuticals price target raised to $54 from $52 at JPMorgan
The FlyXenon Pharmaceuticals price target raised to $54 from $52 at JPMorgan
3M ago
XENE
Xenon Pharmaceuticals initiated with a Buy at Goldman Sachs
The FlyXenon Pharmaceuticals initiated with a Buy at Goldman Sachs
3M ago
XENE
Xenon Pharmaceuticals initiated with an Outperform at Cowen on XEN1101 optimism
The FlyXenon Pharmaceuticals initiated with an Outperform at Cowen on XEN1101 optimism
3M ago
XENE
Xenon Pharmaceuticals initiated with an Outperform at Cowen
The FlyXenon Pharmaceuticals initiated with an Outperform at Cowen
3M ago
XENE
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)
Press ReleasesXenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)
4M ago
XENE
Xenon Pharmaceuticals provides updates on neurology programs at AES 2022
The FlyXenon Pharmaceuticals provides updates on neurology programs at AES 2022
4M ago
XENE
Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022
Press ReleasesXenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022
4M ago
XENE
Xenon Pharmaceuticals initiated with an Overweight at Wells Fargo
The FlyXenon Pharmaceuticals initiated with an Overweight at Wells Fargo
4M ago
XENE
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Press ReleasesXenon Pharmaceuticals to Participate in Upcoming Investor Conferences
4M ago
XENE
Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Press ReleasesXenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
5M ago
XENE
Xenon Pharmaceuticals appoints DiFabio as CLO, Corporate Secretary
The FlyXenon Pharmaceuticals appoints DiFabio as CLO, Corporate Secretary
5M ago
XENE
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
Press ReleasesXenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
5M ago
XENE
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
Press ReleasesXenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
5M ago
XENE
Xenon Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
Press ReleasesXenon Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
7M ago
XENE
J.P. Morgan Says the Stock Market Is Poised for More Upside; Here Are 2 Stocks the Banking Giant Likes
Stock Analysis & IdeasJ.P. Morgan Says the Stock Market Is Poised for More Upside; Here Are 2 Stocks the Banking Giant Likes
7M ago
BGNE
XENE
Xenon Pharmaceuticals Announces Closing of $287.5 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Press ReleasesXenon Pharmaceuticals Announces Closing of $287.5 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
9M ago
XENE
Xenon Pharmaceuticals Announces Pricing of $250.0 Million Public Offering
Press ReleasesXenon Pharmaceuticals Announces Pricing of $250.0 Million Public Offering
9M ago
XENE
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.